Essure, a Procedure for Female Birth Control, Gets New Restrictions From the FDA.

The following is taken without editing from the FDA
site:https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/EssurePermanentBirthControl/ucm452254.htm

FDA Activities: Essure

The FDA continues to monitor the safety of Essure. Women considering permanent birth control should make fully informed decisions by getting information from their health care provider about the risks and benefits of all options. The FDA continues to believe that the benefits of the device outweigh its risks, and that Essure’s updated labeling and the sales restriction help to assure that women are appropriately informed of the risks. The following is an overview of some of the FDA’s efforts to monitor the safety of Essure.

FDA Restricts the Sale and Distribution of Essure

The FDA wants to ensure that each and every woman who receives Essure has been informed of the risks and benefits before getting the device implanted. The FDA has taken steps, including labeling changes in 2016 adding a boxed warning and patient decision checklist, to better inform health care providers and patients about the risks.

The FDA is aware that some women have received the Essure device without being adequately informed of Essure’s risks. In order for this device to meet reasonable assurance of safety and effectiveness, all women considering Essure should receive this important information.

On April 9, 2018, the FDA restricted sales of the Essure device to only doctors and healthcare facilities who use the FDA-approved “Patient-Doctor Discussion Checklist – Acceptance of Risk and Informed Decision Acknowledgement”. Sale and distribution of Essure is limited to healthcare providers who agree to review this checklist with patients, and give them the opportunity to sign it, before Essure implantation. The FDA has approved this new safety measure to ensure that the device meets our standards for a reasonable assurance of safety and effectiveness.

The FDA also approved Bayer’s new labeling that includes:

Addendum from Dr. Seaman:

Also from the FDA:

Long-term risks to patients reported in clinical trials include:

Vasectomy continues to be a safe and effective method of permanent birth control for men.

You Might Also Enjoy...

What Causes Blockage in the Reproductive System?

Are you struggling with infertility? For couples affected by male infertility, reproductive system blockage is often to blame. Learn more about the male reproductive system, common causes of blockage, and what you can do to improve your fertility.

The Link Between Obesity and ED

Obesity is a major health issue for American men. It increases your risk of serious conditions like heart disease and diabetes — and it also affects your sex life. Obesity is linked to erectile dysfunction, and now’s the time to learn more.

Seven Symptoms of Kidney Stones

Kidney stones are common, but varying sizes and shapes mean symptoms aren’t always the same. Learn to recognize the most common symptoms of kidney stones, from lower back pain to foul-smelling urine, so you can get the treatment you need.

Men Suffer From Hormone Imbalance Too

Hormone imbalance is often labeled as a women’s health issue. While it’s true that hormonal changes in menopause trigger notorious symptoms, men are at risk for hormone imbalance too. Learn more about low testosterone and how it can be treated.

What Is a Varicocele?

A varicocele is an enlarged vein in your scrotum, and it’s a leading cause of male infertility. Learn the signs and symptoms of varicoceles and what your treatment options are here.